Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy

Inclusion Criteria: * The patient is 18-80 years of age. * The patient has provided written informed consent. * The patient is scheduled for hip arthroscopy surgery for treatment of FAI * The patient has an ASA of I, II, or III. * The patients understands the explanation of the protocol. Exclusion Criteria: * The patient has history of a major GI bleeding event * The patients has a history of renal impairment or creatinine \> 1.5 * The patient has taken NSAIDs within 48 hours of surgery or in the perioperative period * The patient has a history of heterotopic ossification following surgery * The patient has a hypersensitivity reaction to Naproxen * The patient is undergoing a concomitant procedure in addition to treatment of FAI